StockGuru Blog: IncreMental Advantage Research Report Indicates Immune Response Could Become Quite Profitable Even With Low Market Penetration Rates
IMNR - The Immune Response Corporation IncreMental Advantage, an equity research firm, has initiated coverage of The Immune Response Corporation…